Name: Latest research reports of Windlas Biotech Ltd. authored by Ashika Research and published by - Trendlyne research reports.
Item: Windlas Biotech Ltd.
Rating: 3
Author: Ashika Research

Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329 | ISIN: INE0H5O01029 | Industry: Pharmaceuticals
| Mid-range Performer

777.7000 40.65 (5.52%)

NSE Dec 19, 2025 15:31 PM

31.78% Fall from 52W High

Volume: 47,150

Windlas Biotech Ltd.

04 Aug 2021

777.70

5.52%

Windlas Biotech Ltd. IPO Note

IPO Note: Windlas Biotech Ltd.

Ashika Research

5 each, (Comprising of fresh issue of 3,586,957 Equity Shares* (Rs. 165 cr.) and Offer for Sale of 5,142,067 Equity Shares (Rs. 236.5 cr.*) by Selling Shareholder)....

Windlas Biotech has lost -26.40% in the last 1 Year